1. Home
  2. NVAX vs EVCM Comparison

NVAX vs EVCM Comparison

Compare NVAX & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • EVCM
  • Stock Information
  • Founded
  • NVAX 1987
  • EVCM 2006
  • Country
  • NVAX United States
  • EVCM United States
  • Employees
  • NVAX N/A
  • EVCM N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • EVCM EDP Services
  • Sector
  • NVAX Health Care
  • EVCM Technology
  • Exchange
  • NVAX Nasdaq
  • EVCM Nasdaq
  • Market Cap
  • NVAX 2.0B
  • EVCM 2.0B
  • IPO Year
  • NVAX 1995
  • EVCM 2021
  • Fundamental
  • Price
  • NVAX $9.76
  • EVCM $10.75
  • Analyst Decision
  • NVAX Buy
  • EVCM Buy
  • Analyst Count
  • NVAX 6
  • EVCM 11
  • Target Price
  • NVAX $17.83
  • EVCM $11.45
  • AVG Volume (30 Days)
  • NVAX 7.2M
  • EVCM 68.3K
  • Earning Date
  • NVAX 11-07-2024
  • EVCM 11-12-2024
  • Dividend Yield
  • NVAX N/A
  • EVCM N/A
  • EPS Growth
  • NVAX N/A
  • EVCM N/A
  • EPS
  • NVAX N/A
  • EVCM N/A
  • Revenue
  • NVAX $987,667,000.00
  • EVCM $691,687,000.00
  • Revenue This Year
  • NVAX N/A
  • EVCM $4.47
  • Revenue Next Year
  • NVAX N/A
  • EVCM $5.08
  • P/E Ratio
  • NVAX N/A
  • EVCM N/A
  • Revenue Growth
  • NVAX N/A
  • EVCM 6.23
  • 52 Week Low
  • NVAX $3.53
  • EVCM $6.22
  • 52 Week High
  • NVAX $23.86
  • EVCM $12.35
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 36.20
  • EVCM 60.86
  • Support Level
  • NVAX $9.52
  • EVCM $10.42
  • Resistance Level
  • NVAX $10.63
  • EVCM $10.90
  • Average True Range (ATR)
  • NVAX 0.57
  • EVCM 0.19
  • MACD
  • NVAX -0.12
  • EVCM 0.04
  • Stochastic Oscillator
  • NVAX 9.97
  • EVCM 88.61

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

About EVCM EverCommerce Inc.

EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is primarily generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts..

Share on Social Networks: